Health Care — Top 3
Ranked inside one sector of the Asia universe, where the score is the plain four-component score: the sector blend is switched off because inside a single sector it would be the rank order itself.
85 active instruments in this market · 3 of 3 carry a computed quality rank · newest bar 2026-09-25 · dataset updated 2 days ago
0 of 85 instruments in this market carry headlines. Where a page shows no news, the silence is about coverage rather than about the market.
Top 3 · Health Care · data as of 2026-09-25
| 1 | CSL.AX CSL Limited | Health Care | 66.8 | -1.21% | 63.1 | 2026-09-25 Live | Quality 72 of 100, Trend 75 of 100, Momentum 55 of 100, Liquidity 35 of 100 |
| 2 | 7741.T HOYA Corporation | Health Care | 60.8 | 1.49% | 45.5 | 2026-09-25 Live | Quality 80 of 100, Trend 30 of 100, Momentum 55 of 100, Liquidity 51 of 100 |
| 3 | 4502.T Takeda Pharmaceutical Company Limited | Health Care | 60.6 | 1.43% | 61.8 | 2026-09-25 Live | Quality 59 of 100, Trend 75 of 100, Momentum 55 of 100, Liquidity 42 of 100 |
Score is a 0–100 cross-sectional rank, not a return forecast. Quality, trend, momentum and liquidity are the four components shown at the right of each row. RSI 14 is a 14-day relative strength index; a dash means the value is not in the dataset.
3 instruments
Health Care
Average score 62.7 · leader CSL.AX
13 instruments
Information Technology
Average score 60.8 · leader 2317.TW
2 instruments
Utilities
Average score 60.4 · leader 0003.HK
11 instruments
Industrials
Average score 60.1 · leader 6098.T
19 instruments
Financials
Average score 56.2 · leader 8316.T
1 instruments
Real Estate
Average score 54.5 · leader 1113.HK